Please assess the completion status of the following clinical trial:

Trial Title: Residual Vein Thrombosis Establishes the Optimal Duration of Oral Anticoagulants

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* First episode of unprovoked and provoked proximal DVT of the lower limbs and treated for 3 month with oral anticoagulants~Exclusion Criteria:~* Active cancer,~* Limited life expectancy,~* Antiphospholipid antibody syndrome, or an other known thrombophilic status (such as antithrombin deficiency),~* Serious liver disease,~* Renal insufficiency (serum creatinine \> 2 mg/dL).

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).